Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Nature Cell Biology|October 28, 2016
DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathwayAlejandro Parrales, Atul Ranjan, Swathi V Iyer, et al.Oncotarget|December 25, 2015
Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activitiesSwathi V Iyer, Alejandro Parrales, Priya Begani, et al.Cell Death Discovery|November 1, 2022
DNAJA1- and conformational mutant p53-dependent inhibition of cancer cell migration by a novel compound identified through a virtual screenShigeto Nishikawa, Atsushi Kaida, Alejandro Parrales, et al.Cancer Cell|February 5, 2021
Mutant p53 suppresses innate immune signaling to promote tumorigenesisMonisankar Ghosh, Suchandrima Saha, Julie Bettke, et al.Nature Communications|November 26, 2016
Genome-wide RNAi screening identifies TMIGD3 isoform1 as a suppressor of NF-κB and osteosarcoma progressionSwathi V Iyer, Atul Ranjan, Harold K Elias, et al.Cancers|September 9, 2022
Mutant p53 Depletion by Novel Inhibitors for HSP40/J-Domain Proteins Derived from the Natural Compound PlumbaginMohamed Alalem, Mrinalini Bhosale, Atul Ranjan, et al.Journal of Materials Science. Materials in Medicine|December 26, 2025
A comparison of poly(methyl methacrylate) and silorane-based cements as carriers for local doxorubicin deliveryGrahmm A Funk, Elizabeth M Menuey, Zachary D Denton, et al.Plos One|March 27, 2018
Comparative oncology approach to drug repurposing in osteosarcomaAlejandro Parrales, Peter McDonald, Megan Ottomeyer, et al.Oncogene|June 29, 2021
DNAJA1 promotes cancer metastasis through interaction with mutant p53Atsushi Kaida, Satomi Yamamoto, Alejandro Parrales, et al.Cancers|December 11, 2025
MicroRNA Profiling Identifies Diagnostic and Prognostic Markers in Pediatric SarcomaTerrie G Flatt, Leonid M Yermakov, Shreeram Akilesh, et al.Pageof 3